Diamond Biofund Inc. (TPE:6901)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.95
+0.45 (2.57%)
Aug 7, 2026, 1:30 PM CST

Diamond Biofund Financials Overview

Millions TWD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-863.18-1,073-2,229-2,4401,0163,064
Revenue Growth
-----66.85%-52.88%
Gross Profit
-863.18-1,073-2,229-2,4401,0163,064
Operating Income
-1,006-1,221-2,410-2,598902.242,988
Net Income
-959.66-1,175-2,518-2,583797.782,852
Earnings Per Share
-1.13-1.38-2.96-3.321.043.52
EPS Growth
-----70.45%-60.43%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
3,7373,8915,1309,64710,73810,087
Total Debt
87.8593.93117.83129.013.6741.99
Net Cash (Debt)
3,6493,7975,0129,51810,73410,045
Net Cash Growth
-26.09%-24.24%-47.34%-11.33%6.86%51.82%
Net Cash Per Share
4.284.465.8912.2213.9512.41

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-225.3-264.061,139-2,568473.09-300.42
Capital Expenditures
-0-0.19-14.24-19.11-1.46-
Free Cash Flow
-225.3-264.251,125-2,587471.63-300.42
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
----100.00%100.00%
Operating Margin
----88.84%97.52%
Pretax Margin
111.07%109.37%107.52%105.92%86.76%96.63%
Profit Margin
----78.55%93.08%
FCF Margin
----46.44%-9.81%

Dividends

Fiscal YearFY 2022FY 2021
Period EndingDec '22 Dec '21
Dividend Per Share
0.1700.200
Dividend Per Share Growth
-15.33%0%
Dividend Yield
0.27%-

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
----60.25-
P/FCF Ratio
--24.72-101.92-
PS Ratio
-17.74-13.10-12.48-16.9947.33-